KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
[at noodls] – SOUTH SAN FRANCISCO, CA (January 31, 2013): KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) today announced the pricing of its previously announced initial public offering of 8,750,000 shares of common stock … more
View todays social media effects on KBIO
View the latest stocks trending across Twitter. Click to view dashboard